Global Pancreatic Cancer Therapeutics Market Share Analysis 2016-2021 May.2017 | Page 7

Global Pancreatic Cancer Therapeutics Market 7.2.1 Bargaining Power of Suppliers 7.2.2 Bargaining Power of Consumers 7.2.3 Threat of New Entrants 7.2.4 Threat of Substitute Products and Services 7.2.5 Competitive Rivalry within the Industry 8. Market Leaders' Analysis 8.1 Eli Lilly 8.1.1 Overview 8.1.2 Type of Product 8.1.3 Financial analysis 8.1.4 Recent Developments 8.1.5 SWOT analysis 8.1.6 Analyst View 8.2 Amgen, Inc. 8.3 Celgene Corp. 8.4 F. Hoffmann-La Roche 8.5 Clovis Oncology Inc. 8.6 Pfizer 8.7 Novartis AG 8.8 Threshold Pharmaceuticals Inc. 8.9 Aduro BioTech Inc. 8.10 Infinity Pharmaceuticals Inc. 8.11 NewLink Genetics Corp. 9. Competitive Landscape 9.1 Market share analysis 9.2 Merger and Acquisition Analysis 9.3 Agreements, collaborations and Joint Ventures 9.4 New Product Launches 10. Market Outlook and Investment Opportunities Appendix a) List of Tables [phone] | www.marketdataforecast.com | [email protected]